MedPath

Evaluation the effect of syrup made from sweet Almond in pediatric nocturnal cough

Phase 3
Conditions
Cough due to upper respiratory tract infection(common cold).
Acute nasopharyngitis [common cold]
Registration Number
IRCT20180527039867N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

The patients's age is two to twelve years old
Cough due to upper respiratory tract infection (common cold) for less than 7 days
Concomitant symptoms (mild fever: less than 39 ° C, sore throat, cramps, rhinorrhea, mild headache, feeling tired, sneezing
Do not use any anti-cough product 18 hours before the intervention
Lack of underlying disease (asthma, allergic rhinitis, sinusitis, laryngo tracheobronchitis, congenital heart disease, chronic lung disease, diabetes, kidney disease)
Conscious written consciously from parents to enter the study
Possibility of patient Follow up

Exclusion Criteria

Children with signs and symptoms of asthma, pneumonia, allergic rhinitis, sinusitis, laryngo tracheobronchitis, congenital heart disease, chronic lung disease, diabetes, kidney disease
The onset of symptoms of otitis, sinusitis, onset of symptoms of of the lower respiratory tract infection , the addition of a bacterial infection to the viral infection (edema, respiratory problem, severe sore throat with painful ingestion, nausea, vomiting, fever above 39 °, septic nasal discharge, Facial and peri orbital pain) during the intervention
Lack of allergy (presence of symptoms such as i itchy eye & nose, a history of prolonged cold periods,history of repeating similar symptoms, positive family history of allergy, history of drug and food allergy),
The presence of sign and symptoms of a Reactive Airway Disease including: tachypnea and tachycardia, short breath, chest tightness )
Getting any anti cough drug before intervention
Not using or using irregularly recommended medications
Add other cough drugs to treatment during the intervention
allergic reaction to drug combinations during the study
disrelish to cooperate until the end of the study
Inaccessibility of the patient during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cough frequency. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist.;Cough severity. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist.;Nightly sleep quality of the child. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist.;Nightly sleep quality of the parent. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist.
Secondary Outcome Measures
NameTimeMethod
Time Control Signs. Timepoint: Any time during the study. Method of measurement: Report by the child's parents.
© Copyright 2025. All Rights Reserved by MedPath